DIAGNOSTIC ROLE OF INFLAMMATORY MARKERS IN OVARIAN CANCER: CAN THEY HELP FOR DIFFERENTIAL DIAGNOSIS AMONG BENIGN AND MALIGNANT ADNEXAL MASSES?
cun id:
279
CHEMIOTERAPIA
Severe infections and pneumonia in relapsed/ refractory (R/R) patients with chronic lymphocytic leukemia (CLL) treated in the real world with bendamustine and rituximab (BR) chemoimmunotherapy or the kinase inhibitors (KIs) ibrutinib or idelalisib.
Molecular basis of Notch3-Pin1 functional cross-talk in aggressive female tumors: therapeutic targeting implications in ovarian cancer treatment.
Multimodality cardiovascular monitoring of hematological patients treated by anthracycline: looking for the earlier marker of cardiac damage.
Tubulin as target in chronic myeloid leukemia treatment
Immunochemotherapy and cancer derived exosomes: interplay between Damage Associated Molecular Patterns (DAMPs) and NK cells
Upregulation of NK cell activating ligands and type I interferons in response to genotoxic stress in multiple myeloma: role SAMHD1.
Effetti delle terapie combinate che hanno come bersaglio la via di segnale PI3K/AKT/mTOR ed il recettore per gli androgeni su linee cellulari di cancro della prostata.
Studio della funzione cardiaca in giovani adulti guariti dopo trattamento per un tumore in età pediatrica
Terapia epigenetica anti-tumorale del glioblastoma umano in vitro con inibitori dell'istone metil-transferasi EZH2.